MA27702A1 - Preparation de suspensions aqueuses steriles comprenant des ingredients actifs cristallins micronises, destinees a l'inhalation - Google Patents

Preparation de suspensions aqueuses steriles comprenant des ingredients actifs cristallins micronises, destinees a l'inhalation

Info

Publication number
MA27702A1
MA27702A1 MA28341A MA28341A MA27702A1 MA 27702 A1 MA27702 A1 MA 27702A1 MA 28341 A MA28341 A MA 28341A MA 28341 A MA28341 A MA 28341A MA 27702 A1 MA27702 A1 MA 27702A1
Authority
MA
Morocco
Prior art keywords
sterile aqueous
aqueous suspensions
inhalation
preparation
active ingredients
Prior art date
Application number
MA28341A
Other languages
English (en)
Inventor
Andrea Capocchi
Fausto Pivetti
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MA27702A1 publication Critical patent/MA27702A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/02—Non-contaminated water, e.g. for industrial water supply
    • C02F2103/026—Treating water for medical or cosmetic purposes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

La présente invention concerne un procédé de préparation de suspensions aqueuses stériles constituées d'ingrédients actifs se présentant sous forme de particules cristallines micronisées, destinées à l'administration par inhalation. Cette invention porte plus particulièrement sur la préparation de suspensions aqueuses stériles à base d'ingrédients pharmaceutiques actifs se présentant sous forme d'hydrates cristallins.
MA28341A 2002-12-18 2005-06-16 Preparation de suspensions aqueuses steriles comprenant des ingredients actifs cristallins micronises, destinees a l'inhalation MA27702A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002674A ITMI20022674A1 (it) 2002-12-18 2002-12-18 Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.

Publications (1)

Publication Number Publication Date
MA27702A1 true MA27702A1 (fr) 2006-01-02

Family

ID=32587870

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28341A MA27702A1 (fr) 2002-12-18 2005-06-16 Preparation de suspensions aqueuses steriles comprenant des ingredients actifs cristallins micronises, destinees a l'inhalation

Country Status (22)

Country Link
US (1) US8128909B2 (fr)
EP (1) EP1572153B1 (fr)
CN (1) CN100398095C (fr)
AT (1) ATE544445T1 (fr)
AU (1) AU2003294879A1 (fr)
BR (1) BRPI0316908B8 (fr)
CA (1) CA2510263C (fr)
DK (1) DK1572153T3 (fr)
EA (1) EA008122B1 (fr)
ES (1) ES2379349T3 (fr)
HR (1) HRP20050546B1 (fr)
IT (1) ITMI20022674A1 (fr)
MA (1) MA27702A1 (fr)
ME (2) MEP35208A (fr)
MX (1) MXPA05006441A (fr)
PL (1) PL213704B1 (fr)
PT (1) PT1572153E (fr)
RS (1) RS52151B (fr)
SI (1) SI1572153T1 (fr)
UA (1) UA87655C2 (fr)
WO (1) WO2004054545A1 (fr)
ZA (1) ZA200504897B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
ITMI20020808A1 (it) * 2002-04-17 2003-10-17 Chiesi Farma Spa Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
ITMI20032054A1 (it) * 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
EP1811981B1 (fr) 2004-10-12 2008-08-13 Merck Generics (UK) Limited Procede pour la preparation d'une suspension a pulveriser, caracterise en ce que les particules sont formees a l'interieur du flacon d'aerosol
EP1949891A1 (fr) * 2004-10-12 2008-07-30 Generics (UK) Limited Procédé pour la préparation de formules à suspension pour aérosol, caractérisé en ce que les particles soient formées par précipitation à l'intérieur d'un récipient
EP1683514B1 (fr) 2005-01-20 2012-05-23 Eratech S.r.l. Procédé de préparation de suspensions concentrées et une trousse de ceci
EP1782797A1 (fr) * 2005-11-02 2007-05-09 Pharmatex Italia Srl Procédé de préparation de composés pharmaceutiques stériles pulvérulents
CA2683712A1 (fr) * 2007-04-20 2009-01-15 Sun Pharmaceutical Industries Limited Compositions pharmaceutiques
JP4879349B2 (ja) 2007-07-31 2012-02-22 大塚製薬株式会社 アリピプラゾール懸濁液及び凍結乾燥製剤の製造方法
US20100266696A1 (en) * 2007-12-13 2010-10-21 Gerhard Muhrer Organic Compounds
GB0806873D0 (en) * 2008-04-16 2008-05-21 Breath Ltd Steroid nebuliser formulation
CN101618019B (zh) * 2008-07-01 2011-08-03 上海通用药业股份有限公司 一种醋酸曲安奈德微粒及其制备方法和药物组合物
JP5934719B2 (ja) 2011-01-12 2016-06-15 インターベット インターナショナル ベー． フェー． 薬物懸濁液の調製におけるクロスフロー濾過を用いた液体培地交換の使用
RU2611665C2 (ru) 2011-05-03 2017-02-28 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Улучшенный состав суспензии кортикостероида для ингаляционного введения
JP4954345B1 (ja) * 2011-07-06 2012-06-13 アピ株式会社 医薬品原薬の無菌化精製装置
CN107880091B (zh) * 2012-05-08 2020-12-18 尼科斯眼药公司 疏水性治疗剂的制剂、其制备方法及应用
DE102012221219B4 (de) * 2012-11-20 2014-05-28 Jesalis Pharma Gmbh Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
SG11201700536XA (en) 2014-09-09 2017-02-27 Vectura Ltd Formulation comprising glycopyrrolate, method and apparatus
ES2764495T3 (es) * 2015-10-09 2020-06-03 Bgh Procedimiento para cristalizar clatratos hidratos y procedimiento de purificación de un líquido acuoso usando los clatratos hidratos así cristalizados
WO2024180569A1 (fr) * 2023-03-01 2024-09-06 Ajaykumar Balraj Kanduri Suspension de nébulisation aqueuse synergique pour la gestion de troubles respiratoires infectieux et processus de préparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107715B (en) * 1981-10-19 1985-11-13 Glaxo Group Ltd Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
DK1073417T3 (da) 1998-04-18 2003-03-24 Glaxo Group Ltd Farmaceutisk aerosolformulering
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
IT1303692B1 (it) 1998-11-03 2001-02-23 Chiesi Farma Spa Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
ES2318145T3 (es) * 2002-02-19 2009-05-01 Resolution Chemicals Limited Esterilizacion de esteroides por medio de disolventes.

Also Published As

Publication number Publication date
MXPA05006441A (es) 2005-09-08
PT1572153E (pt) 2012-03-22
AU2003294879A1 (en) 2004-07-09
ATE544445T1 (de) 2012-02-15
EP1572153A1 (fr) 2005-09-14
MEP35208A (bs) 2011-02-10
HRP20050546B1 (hr) 2014-05-23
EA008122B1 (ru) 2007-04-27
CA2510263C (fr) 2012-07-03
ZA200504897B (en) 2006-09-27
ITMI20022674A1 (it) 2004-06-19
WO2004054545A1 (fr) 2004-07-01
BRPI0316908B8 (pt) 2021-05-25
ME01084B (me) 2011-05-10
US8128909B2 (en) 2012-03-06
EA200500833A1 (ru) 2006-02-24
CA2510263A1 (fr) 2004-07-01
CN100398095C (zh) 2008-07-02
EP1572153B1 (fr) 2012-02-08
SI1572153T1 (sl) 2012-05-31
CN1735403A (zh) 2006-02-15
RS52151B (sr) 2012-08-31
ES2379349T3 (es) 2012-04-25
PL213704B1 (pl) 2013-04-30
UA87655C2 (ru) 2009-08-10
RS72504A (sr) 2006-10-27
HRP20050546A2 (en) 2005-10-31
DK1572153T3 (da) 2012-03-05
PL377345A1 (pl) 2006-01-23
BRPI0316908B1 (pt) 2016-01-26
US20070140980A1 (en) 2007-06-21
HK1088217A1 (zh) 2006-11-03
BR0316908A (pt) 2005-10-18

Similar Documents

Publication Publication Date Title
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
MY127718A (en) Dolastatin 10 derivatives.
EP1659111A3 (fr) Derives de piperidine utiles comme des antagonistes de ccr5
BRPI0316908B8 (pt) preparo de suspensões aquosas estéreis incluindo ingredientes ativos cristalinos micronizados para inalação
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TNSN07476A1 (fr) Derives de n-(pyridine -2- yl) - sulfonamide
MA29171B1 (fr) Formulation a compression directe et procede associe
MXPA05008364A (es) Derivados de pirimidina para la prevencion de una infeccion por vih.
UA92181C2 (ru) Производные пиримидина и их применение в терапии и в производстве лекарственного средства для предотвращения и/или лечения болезни альцгеймера
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
HRP20020929A2 (en) Sustained release pharmaceutical cmpositions for parenteral administration of hydrophilic compounds
IL165601A0 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
IL164974A0 (en) Novel compounds and their use
EP1741712A3 (fr) Nebivolol et son sels pharmaceutiques acceptables, procès pour la preparation et compositions pharmaceutiques de nebivolol
NO20034863L (no) Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
BRPI0304821B8 (pt) processo de preparação de uma suspensão estéril de partículas de corticosteróide para administração por inalação
BR0212069A (pt) Agentes antidiabéticos orais
CA2214026A1 (fr) Compositions pharmaceutiques comprenant des inhibiteurs de la monoamine oxydase b
IL150528A0 (en) Ibuprofen containing active agent preparation
UA86783C2 (ru) Тетразольные производные и способы лечения расстройств, связанных с метаболизмом, с их помощью
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
IL163608A (en) Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders